Counselors in Riverbank, CA Accepting Medicare

4 Counselors found. Showing 1 - 4

Mrs. Kim M Pouv Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 5433 Mayberry Ct, Riverbank, CA 95367 Phone: 209-869-6613

Araceli Vigil, LCSW Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 4150 Patterson Road, Riverbank, CA 95367 Phone: 209-863-3990    Fax: 209-863-3999

Mrs. Maria A Pasillas Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6811 Oakdale Rd, Riverbank, CA 95367 Phone: 209-869-4019    Fax: 209-869-4019

Jose T Andalon Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3525 Hawaii Ave, Riverbank, CA 95367 Phone: 209-719-8105    Fax: 209-269-3225

News Archive

Women's health pioneer receives inaugural Linda Joy Pollin Heart Health Leadership Award

Women's health pioneer Molly Carnes, MD, MS, has been awarded the inaugural Linda Joy Pollin Heart Health Leadership Award from the Barbra Streisand Women's Heart Center in the Cedars-Sinai Heart Institute.

ALS-ETF, Denovo partner to explore personalized medicine approach for ALS

The ALS Emergency Treatment Fund and Denovo Biomarkers have announced a partnership to explore using Denovo's technology to identify potential responder groups for drugs being studied in ALS patients.

Increased heart rate as a physiological response to SARS-CoV-2 mRNA vaccine

Although widely publicized, evidence for physiological responses to the vaccines is currently scarce in published literature. Giogiro Quer and Matteo Gadaleta of the Scripps Research Translational Institute in California, USA, led an investigation to obtain tracking data for physiological responses to vaccine programs.

Acetylcholine can weaken synaptic connections between neurons in brain

Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.

InVivo Therapeutics files an Investigational Device Exemption application with the FDA

InVivo Therapeutics Corporation has filed an Investigational Device Exemption application with the Food and Drug Administration requesting permission to advance to human clinical studies. InVivo is currently conducting its third primate study and expects to receive approval to begin a human study in 2010.

Read more Medical News

› Verified 3 days ago